SMTL ID : 2wgj.1

X-ray Structure of PF-02341066 bound to the kinase domain of c-Met

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x VGH: 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine(Non-covalent)

VGH.1: 17 residues within 4Å: Chain A: I.35, G.36, V.43, A.59, L.91, L.108, P.109, Y.110, M.111, K.112, G.114, R.159, N.160, M.162, A.172, D.173, Y.181 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.43, A:L.108, A:Y.181 Hydrogen bonds: A:P.109, A:M.111 pi-Stacking: A:Y.181 Halogen bonds: A:I.35

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cui, J.J. et al., Structure Based Drug Design of Crizotinib (Pf-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (C-met) Kinase and Anaplastic Lymphoma Kinase (Alk). J.Med.Chem (2011)

Release Date

2009-06-02

Peptides

HEPATOCYTE GROWTH FACTOR RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

HEPATOCYTE GROWTH FACTOR RECEPTOR

Related Entries With Identical Sequence